The poor aqueous solubility of hydrophobic drugs has always been a challenge for formulation scientists. One approach to increase the dissolution rate of hydrophobic drugs is the use of solid dispersion that involves the molecular mixing of the drug with hydrophilic polymers. In addition to increased wettability of the drug, the drug can be prepared in the amorphous form which is associated with higher dissolution rate than the crystalline form. However, this form is physically unstable and materials tend to form the more stable crystalline form. In this thesis, the focus was on increasing the physical stability of amorphous hydrophobic drugs. The hypothesis was based on hydrogen bonding between the drug and the polymer. The model drugs con...
Amorphous solid dispersions are known to enhance solubility of poorly aqueous-soluble drugs and subs...
Solubility of active pharmaceutical agents is a crucial process that determines drug absorption and ...
The most common characteristic which pharmaceutical scientists encounter in context to new drug cand...
The poor aqueous solubility of hydrophobic drugs has always been a challenge for formulation scienti...
The poor water solubility of many drugs has emerged as one of the major challenges in the pharmaceut...
The aim of the study was to prepare molecular dispersions of a physically highly unstable amorphous ...
The oral route is a convenient and most often used route of drug administration to patients. Adequat...
Amorphous solid dispersions are known to improve the oral bioavailability of poorly water-soluble dr...
textIt is estimated that 90% of new chemical entities in development pipelines exhibit poor aqueous ...
The purpose of this study was to investigate the potential of applying amorphous solid dispersions (...
This research study aimed to develop a new strategy for using a polymer blend in solid dispersion (S...
Amorphous solid dispersion (ASD) of a poorly soluble active pharmaceutical ingredient (API) in a pol...
University of Minnesota Ph.D. dissertation. August 2018. Major: Chemical Engineering. Advisors: Fran...
With the advent of combinatorial chemistry and high throughput screening of drug molecules, poorly w...
Polymers are often used to stabilize amorphous drug formulations enabling the maintenance of high dr...
Amorphous solid dispersions are known to enhance solubility of poorly aqueous-soluble drugs and subs...
Solubility of active pharmaceutical agents is a crucial process that determines drug absorption and ...
The most common characteristic which pharmaceutical scientists encounter in context to new drug cand...
The poor aqueous solubility of hydrophobic drugs has always been a challenge for formulation scienti...
The poor water solubility of many drugs has emerged as one of the major challenges in the pharmaceut...
The aim of the study was to prepare molecular dispersions of a physically highly unstable amorphous ...
The oral route is a convenient and most often used route of drug administration to patients. Adequat...
Amorphous solid dispersions are known to improve the oral bioavailability of poorly water-soluble dr...
textIt is estimated that 90% of new chemical entities in development pipelines exhibit poor aqueous ...
The purpose of this study was to investigate the potential of applying amorphous solid dispersions (...
This research study aimed to develop a new strategy for using a polymer blend in solid dispersion (S...
Amorphous solid dispersion (ASD) of a poorly soluble active pharmaceutical ingredient (API) in a pol...
University of Minnesota Ph.D. dissertation. August 2018. Major: Chemical Engineering. Advisors: Fran...
With the advent of combinatorial chemistry and high throughput screening of drug molecules, poorly w...
Polymers are often used to stabilize amorphous drug formulations enabling the maintenance of high dr...
Amorphous solid dispersions are known to enhance solubility of poorly aqueous-soluble drugs and subs...
Solubility of active pharmaceutical agents is a crucial process that determines drug absorption and ...
The most common characteristic which pharmaceutical scientists encounter in context to new drug cand...